NDC 55513-843 – Aimovig

Erenumab 140 mg/mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC55513-843

Product details

Brand name
Aimovig
Generic name
Erenumab-aooe
Labeler
Amgen, Inc
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
BLA · BLA761077
Marketed since
March 15, 2019
Listing expires
December 31, 2027

Active ingredients

Uses, dosage, side effects and warnings for Aimovig →

Package NDC codes (2)

Package NDCDescriptionSince
55513-843-001 SYRINGE in 1 CARTON (55513-843-00) / 1 mL in 1 SYRINGEMar 15, 2019
55513-843-011 SYRINGE in 1 CARTON (55513-843-01) / 1 mL in 1 SYRINGEMar 15, 2019

Other Aimovig products